Epidemiology: clues to the pathogenesis of Burkitt lymphoma

被引:114
作者
Magrath, Ian [1 ,2 ,3 ]
机构
[1] Int Network Canc Treatment & Res, B-1180 Brussels, Belgium
[2] Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA
[3] NCI, Bethesda, MD 20892 USA
关键词
epidemiology; Burkitt; lymphoma; malaria; Epstein-Barr; EPSTEIN-BARR-VIRUS; HUMAN-IMMUNODEFICIENCY-VIRUS; HEPATITIS-C VIRUS; T-CELL LEUKEMIA; HEPATOCELLULAR-CARCINOMA; GEOGRAPHICAL-DISTRIBUTION; NASOPHARYNGEAL CARCINOMA; PAPILLOMAVIRUS DNA; INFECTIOUS AGENTS; PARTICLE VACCINE;
D O I
10.1111/j.1365-2141.2011.09013.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The two major epidemiological clues to the pathogenesis of Burkitt lymphoma (BL) are the geographical association with malaria - BL incidence relates to the malaria transmission rate - and early infection by Epstein- Barr virus (EBV). Both agents cause B cell hyperplasia, which is almost certainly an essential component of lymphomagenesis in BL. The critical event in lymphomagenesis is the creation of a MYC translocation, bringing the MYC gene into juxtaposition with immunoglobulin genes and causing its ectopic expression, thereby driving the proliferation of BL cells. It is highly likely that such translocations are mediated by the activation- induced cytidine deaminase (AID) gene, which is responsible for hypervariable region mutations as well as class switching. Stimulation of the Toll- like receptor 9 by malaria- associated agonists induces AID, providing a mechanism whereby malaria could directly influence BL pathogenesis. EBV- containing cells must reach the memory cell compartment in order to survive throughout the life of the individual, which probably requires traversal of the germinal centre. Normally, cells that do not produce high affinity antibodies do not survive this passage, and are induced to undergo apoptosis. EBV, however, prevents this, and in doing so may also enhance the likelihood of survival of rare translocation- containing cells.
引用
收藏
页码:744 / 756
页数:13
相关论文
共 105 条
[21]   Infectious Agents and Colorectal Cancer: A Review of Helicobacter pylori, Streptococcus bovis, JC Virus, and Human Papillomavirus [J].
Burnett-Hartman, Andrea N. ;
Newcomb, Polly A. ;
Potter, John D. .
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2008, 17 (11) :2970-2979
[22]  
Carrillo-Infante C, 2007, INT J ONCOL, V30, P1521
[23]   The Increasing Burden of HIV-Associated Malignancies in Resource-Limited Regions [J].
Casper, Corey .
ANNUAL REVIEW OF MEDICINE, VOL 62, 2011, 2011, 62 :157-170
[24]   Decreased Incidence of Hepatocellular Carcinoma in Hepatitis B Vaccinees: A 20-Year Follow-up Study [J].
Chang, Mei-Hwei ;
You, San-Lin ;
Chen, Chien-Jen ;
Liu, Chun-Jen ;
Lee, Chuan-Mo ;
Lin, Shi-Ming ;
Chu, Heng-Cheng ;
Wu, Tzee-Chung ;
Yang, Sheng-Shun ;
Kuo, Hsu-Sung ;
Chen, Ding-Shinn .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2009, 101 (19) :1348-1355
[25]   Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children [J].
Chang, MH ;
Chen, CJ ;
Lai, MS ;
Hsu, HM ;
Wu, TC ;
Kong, MS ;
Liang, DC ;
Shau, WY ;
Chen, DS .
NEW ENGLAND JOURNAL OF MEDICINE, 1997, 336 (26) :1855-1859
[26]   ISOLATION OF A CDNA CLONE DERIVED FROM A BLOOD-BORNE NON-A, NON-B VIRAL-HEPATITIS GENOME [J].
CHOO, QL ;
KUO, G ;
WEINER, AJ ;
OVERBY, LR ;
BRADLEY, DW ;
HOUGHTON, M .
SCIENCE, 1989, 244 (4902) :359-362
[27]   Cancer risk in the swiss HIV cohort study: Associations with immunodeficiency, smoking, and highly active antiretroviral therapy [J].
Clifford, GM ;
Polesel, J ;
Rickenbach, M ;
Dal Maso, L ;
Keiser, O ;
Kofler, A ;
Rapiti, E ;
Levi, F ;
Jundt, G ;
Fisch, T ;
Bordoni, A ;
De Weck, D ;
Franceschi, S .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2005, 97 (06) :425-432
[28]  
Coakley D., 2007, IRISH MASTERS MED
[29]   The geographical distribution of Kaposi's sarcoma and of lymphomas in Africa before the AIDS epidemic [J].
Cook-Mozaffari, P ;
Newton, R ;
Beral, V ;
Burkitt, DP .
BRITISH JOURNAL OF CANCER, 1998, 78 (11) :1521-1528
[30]   Causes of cancer in the world: comparative risk assessment of nine behavioural and environmental risk factors [J].
Danaei, G ;
Vander Hoorn, S ;
Lopez, AD ;
Murray, CJL ;
Ezzati, M .
LANCET, 2005, 366 (9499) :1784-1793